humans with reduced Stat3 expression in the myocardium (16) .
Mitochondria from the hearts of Stat3 flox/flox/cre (Stat3 -/-) and Stat3 flox/flox (wild type) mice were assayed for complex I and II activity. The mice used for these studies were 8 weeks old, at which time the hearts are normal as analyzed by histology and various physiological parameters (15) . We used pyruvate and malate as complex I substrates (upper panels) and succinate as a complex II substrate (lower panels) to measure O 2 consumption in WT and Stat3
-/-heart mitochondria (Fig. 4) . Rates of O 2 consumption were decreased in Stat3
-/-mitochondria with both substrates. Maximal rates of state 3 respiration (V max ) stimulated by the addition of 2 mM ADP were blunted in Stat3
-/-mitochondria. Pyruvate and malate V max in state 3 was decreased by~30% and succinate state 3 V max by~60% (table S1).
ETC assays confirmed that Stat3
-/-heart mitochondria had defects in complexes I and II but had normal activity of complex III ( fig. S4 ).
The results presented here reveal a role of Stat3 as a modulator of mitochondrial respiration. The most likely mechanism by which Stat3 exerts its actions is not as a transcription factor that regulates nuclear gene expression, but rather through its localization in the mitochondria. The effects of Stat3 potentially represent a general mechanism by which this protein can influence cell metabolism. These studies are consistent with the concept of multidirectional communication between the mitochondria and the nucleus and changes in homeostasis detected at the plasma membrane. The precise mechanism by which Stat3 regulates complexes I and II remains to be determined. Platelets play a critical role in the pathogenesis of malarial infections by encouraging the sequestration of infected red blood cells within the cerebral vasculature. But platelets also have well-established roles in innate protection against microbial infections. We found that purified human platelets killed Plasmodium falciparum parasites cultured in red blood cells. Inhibition of platelet function by aspirin and other platelet inhibitors abrogated the lethal effect human platelets exert on P. falciparum parasites. Likewise, platelet-deficient and aspirin-treated mice were more susceptible to death during erythrocytic infection with Plasmodium chabaudi. Both mouse and human platelets bind malarial-infected red cells and kill the parasite within. These results indicate a protective function for platelets in the early stages of erythrocytic infection distinct from their role in cerebral malaria.
A daptive immunity to malarial infection accumulates slowly over the lifetime of an individual living in an endemic region. Cross-immunity between isolates is low, and every new infection requires the development of a virtually novel immune response. Therefore, innate mechanisms that limit parasite growth within the red blood cell (RBC) are extremely important in determining survival, especially during the first few years of life, because clinical severity correlates closely with parasite mass. Several known mutations affect the RBC and decrease the severity of infection through either impediment of parasite entry or development within the cell (1). However, we know little about other non-RBC mechanisms that may influence the course of infection before the onset of effective adaptive immune responses.
Thrombocytopenia is a common clinical accompaniment of Plasmodium falciparum (2-4), Plasmodium vivax (5, 6), and Plasmodium chabaudi (7) malarial infections. Low platelet concentrations correlate with increased parasite density (8, 9) and poor outcome (10) . Platelets bind preferentially to infected RBCs (11, 12) and have been postulated to play a role in the pathogenesis of malarial infection, either positively (13, 14) or negatively (15, 16) . Given the role platelets play in other infectious diseases (17), we explored their influence on the course of a malarial infection in the mouse model, P. chabaudi, and in vitro using the cultured human malarial parasite, P. falciparum.
The megakaryocyte growth and differentiation factor, C-mpl, is the receptor for thrombopoietin and is encoded by the Mpl gene. Homozygous disruption of the Mpl gene on a C57BL/6 background (Mpl
) results in mice with only one-tenth as many circulating platelets as their undisrupted counterparts have (18) . Platelet-deficient Mpl −/− mice were significantly more susceptible to death from P. chabaudi than were isogenic C57BL/6 mice (P < 0.0001, Mantel-Cox log-rank test on survival data), irrespective of well-known sex differences. In females, 5% of C57BL/6 versus 50% of Mpl −/− mice died. Twenty percent of the male C57BL/6 mice and all the male Mpl −/− mice died ( Fig. 1, A and B) .
Cohort analysis of groups of mice showed that platelet numbers decreased concomitantly with the appearance of parasites in the peripheral circulation ( −/− and C57BL/6 mice during both malarial challenge and experimentally induced hemolysis (figs. S1 and S2), excluding differential erythropoiesis as a cause for the different susceptibilities. Nor were differences in immunological responses, including production of lymphocytes and inflammatory cytokines, observed between the mouse strains during infection ( fig. S3 ).
Acetyl salicylic acid (aspirin) inhibits cyclooxygenases I and II, resulting in a decrease in thromboxane A2 and decreased platelet activation as seen by lower platelet aggregation (19) . Mice were given 25 mg of aspirin per kilogram of body weight intraperitoneally daily from the day before P. chabaudi infection until day 10 of infection and monitored for survival. C57BL/6 and Mpl −/− mice of both sexes treated with aspirin were significantly more susceptible than placebo-treated mice (Fig. 1, C and D) (Cox proportional hazard analysis, P = 0.0009). Thus, pharmacological inhibition of platelet function increases susceptibility to malarial infection in mice, although other indirect effects of aspirin cannot be excluded.
Synchronized cultures of P. falciparum trophozoites were grown in human RBCs and incubated with increasing concentrations of purified human platelets. A concentration-dependent increase in the inhibition of parasite growth was observed ( Fig. 2A) . Growth inhibition (measured after 44 hours of incubation) peaked at 65% with 25 to 75 million platelets/ml. Most viable parasites observed at this time were mature trophozoites and shizonts. Reductions in mature shizonts at 5 hours and new rings at 21 to 29 hours ( fig. S4 ) suggest that platelets were inhibiting developmental maturation of the parasites.
Using the P. falciparum model, we investigated the dependence of parasite growth inhibition on platelet function by first incubating platelets with specific platelet antagonists. Maintenance of elevated intracellular adenosine 3´,5´-monophosphate and guanosine 3´,5´-monophosphate concentrations are key mechanisms in suppressing platelet activation (20, 21) . The addition of the adenylyl cyclase activator prostaglandin E1 completely abrogated the platelet growth-inhibitory activity. Exposure of platelets to the guanylyl cyclase activator, NO (donated by sodium nitroprusside), also suppressed platelet-mediated effects on parasite growth (Fig. 2B) . To test for the requirement of adenosine 5´-diphosphate (ADP), an important physiological regulator of platelet activation [reviewed in (20) ], we incubated the platelet-P. falciparum cultures with adenosine diphosphatase (ADPase) (22) to remove extracellular ADP from the culture medium. Unimpeded parasite growth in the presence of platelets and ADPase was observed. ADP-dependent platelet activation is mediated via two metabotrophic puronergic receptors, P2Y 1 and P2Y 12 . Antagonism of P2Y 1 , but not P2Y 12 , abolished the parasite killing activity (Fig. 2B) . Thus, P. falciparum growth is inhibited by platelets in a concentrationdependent and activation-dependent manner that requires ADP and activation through the P2Y 1 receptor. (Fig. 2B ).
As with
To purification. These platelets were unable to inhibit growth of P. falciparum parasites (Fig. 2C) , implying that aspirin is potentially harmful in malarial infections.
In mice infected with P. chabaudi for 8 days, with parasitemias at~10 to 15%, platelets were preferentially bound to infected RBCs. As shown with Giemsa-stained thin smears and light microscopy (Figs. 3A, i and ii) , the percentage parasitemia was twice as high when only platelet-bound RBCs were counted compared with all RBCs (Fig. 3B ). CD41 (a platelet surface antigen) on the surface of RBCs served as a marker for platelet binding. Three times as many infected RBCs stained for CD41 as did uninfected RBCs (Fig.  3C) . Similar results were obtained from cultured P. falciparum, where twice the numbers of infected RBCs were bound by human platelets (counted on Giemsa-stained thin smears) (Fig. 3A, iii and  iv, and 3D ) and twice the number of infected RBCs were also CD41 positive (Fig. 3E) . Therefore, platelets selectively bind infected RBCs.
The presence of dead parasites in the peripheral circulation was investigated by adapting the terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling (TUNEL) technique to thin blood smears. TUNEL stains nuclei containing sheared or degraded DNA, an accompaniment of apoptosis or necrosis. As a positive control, all extraerythrocytic parasites, which commonly occur late in P. chabaudi infections, stained positive for TUNEL ( fig. S5 ). In mice with lower parasitemias (day 7), TUNEL staining of intraerythrocytic parasites was evident (Fig. 4A) , indicative of intraerythrocytic parasite death.
Twice as many dead intraerythrocytic parasites were seen in C57BL/6 mice as in Mpl −/− mice (Fig. 4C) . Although no differences in total parasitemia between Mpl −/− and C57BL/6 were detected at this time point (most TUNEL-stained parasites are morphologically indistinguishable from live parasites), parasitemias measured at later time points were significantly higher in Mpl −/− than in C57BL/6 mice ( fig. S6 ). This suggests that platelet-mediated parasite killing influences parasite numbers past the platelet nadir, resulting in higher parasitemias in Mpl −/− mice, and explains their increased susceptibility.
TUNEL-stained intracellular parasites were also observed in the P. falciparum cultures (Fig.  4B) . The frequency of stained parasites was more than three times as high in platelet-treated cultures (Fig. 4D) . Significantly higher proportions of TUNEL-stained than nonstained infected RBCs were bound by human platelets (by staining with antibodies to CD41) (Fig. 4E) . The greater numbers of dead intraerythrocytic parasites in the presence of normal numbers of platelet in vivo and in vitro implies that platelets directly kill malarial parasites.
Increased mortality in platelet-deficient mice and direct killing of P. falciparum by human platelets indicate that platelets are important in controlling malarial infection. Thrombocytopenia occurs early in infection in both humans and mice, before severe forms of the disease develop (3, 6) . Therefore, the major protective effect of platelets will be early in infection. Modulation of parasite growth by platelets will buffer the parasite growth rate and allow the engagement of the adaptive immune response. This finding is in addition to the well-established role for platelets in cerebral disease (15, 23, 24) . We have also shown that inhibition of platelet activation abrogates the protective effect, which could explain the deleterious effect aspirin may have on malarial outcome (25) .
